LH is a pituitary hormone that signals the gonads to produce sex hormones. In women, LH triggers ovulation mid-cycle; in men, LH stimulates the testes to produce testosterone. Levels are interpreted together with FSH to understand the hypothalamic-pituitary-gonadal axis.
LH patterns reveal whether hormonal issues are at the pituitary level or further downstream. For women, elevated LH with elevated FSH in a menstruating woman may indicate PCOS or approaching menopause; in a postmenopausal woman, high LH and FSH confirm the ovaries have stopped responding. For men, low LH with low testosterone suggests the pituitary isn't signaling adequately (secondary hypogonadism), while high LH with low testosterone suggests the testes aren't responding (primary hypogonadism), very different conditions requiring different interventions.
Optimal Luteinizing Hormone: 2-9 mIU/mL.
Typically re-tested every 10 weeks.
A typical adult lab reference range runs around 1 to 15 mIU/mL. In menstruating women the number swings widely across the cycle, so the day you test can matter as much as the result itself.
Luteinizing hormone is a gonadotropin made by the anterior pituitary gland that acts on the ovaries and testes to drive sex hormone production and, in women, the release of an egg.
The signal starts above the pituitary. The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulses, and those pulses tell specialised pituitary cells called gonadotropes to secrete LH and follicle-stimulating hormone (FSH) into the bloodstream. Because the release is pulsatile, LH in a single blood sample is a snapshot of a signal that rises and falls through the day.
In the ovary, LH stimulates theca cells to make androgens, which neighbouring granulosa cells convert into estradiol under FSH's influence. Late in the follicular phase, rising estradiol flips feedback from negative to positive and produces the mid-cycle LH surge. That surge is what triggers ovulation and then converts the emptied follicle into the corpus luteum, the structure that produces progesterone in the second half of the cycle. Research suggests the pituitary itself remodels to make this possible, with gonadotrope cells reorganising their connections to generate a surge large enough to release an egg[1].
In men the pattern is steadier. LH acts on the Leydig cells of the testes to drive testosterone production, with no monthly surge. Testosterone and estradiol then feed back on the hypothalamus and pituitary to slow LH release, which is why LH and the sex steroids are best read together rather than apart.
LH matters because it is the clearest available read on whether the brain's half of the reproductive axis is working, and sex hormones influence far more than fertility.
Testosterone, estradiol and progesterone all sit downstream of LH. Those hormones are associated with bone density, muscle mass and body composition, lipid and glucose handling, libido, sleep quality and mood. When LH is persistently outside the usual range, the downstream hormone picture is often shifted too, and over years that shift is associated with changes in bone and metabolic health rather than fertility alone.
LH is also a timing marker. In young people, a rising LH response is one of the signals clinicians use when assessing whether puberty has started earlier than expected, and current clinical practice guidance treats gonadotropin measurement as central to that assessment rather than optional[2]. A systematic review of risk factors for precocious puberty reported associations with factors such as higher body mass and certain environmental exposures, though association is not causation and the evidence base is mixed[3].
For adults, the practical value is diagnostic direction rather than prediction. A low testosterone with a high LH points the investigation towards the testes. The same low testosterone with a low or inappropriately normal LH points it towards the pituitary and hypothalamus. One value cannot make either call on its own, but it narrows what is worth discussing with a clinician.
For adults, a typical lab reference range for LH runs from about 1 to 15 mIU/mL, and FitScript's optimal range is narrower.
| Marker | Standard lab reference range | FitScript optimal range |
|---|---|---|
| Luteinizing hormone (adult, outside the mid-cycle surge) | 1 to 15 mIU/mL | 2 to 9 mIU/mL |
In 758 healthy adults aged 18 to 65, LH changed little enough with age in men for one range to cover them, while women's LH rose sharply after menopause.[13]
| Sex | Age | Reference range (IU/L) |
|---|---|---|
| Men | 18 to 65 | 1.39 to 8.12 |
| Women | Before menopause | 2.02 to 42.5 |
| Women | After menopause | 8.4 to 61.1 |
The study split women by menopause rather than by age.[13] Before menopause, LH also changes across the menstrual cycle, with a surge around ovulation, so the day of the cycle matters when reading a result. Your own lab's printed range is the one to read your result against.
These are typical lab reference ranges, and they vary by laboratory, assay, age and sex. FitScript's optimal range is an optimization target used to track a member over time, not a diagnostic cut-off, and a value outside it is not a diagnosis of anything.
Two caveats matter more for LH than for most markers. First, in menstruating women the value changes dramatically across the cycle, rising to a brief peak around ovulation that sits far above the follicular and luteal baselines, so most laboratories report phase-specific ranges and a result is only interpretable alongside the cycle day. Second, after menopause gonadotropins rise substantially as ovarian output falls, and the reference range reported for post-menopausal women is correspondingly much higher. Always read your result against the range printed by the lab that ran the sample.
An LH level above the reference range usually means the pituitary is pushing harder because it is not receiving enough hormonal feedback from the ovaries or testes, though a sample drawn during the ovulatory surge can produce the same number in a completely normal cycle.
People with a persistently elevated LH often report symptoms tied to the low sex hormone state underneath it. In women that can include irregular or absent periods, hot flushes, disrupted sleep, vaginal dryness, low libido and difficulty conceiving. In men it can include fatigue, reduced libido, loss of morning erections, reduced muscle mass and low mood. Many people have no symptoms at all and find the result on a routine panel.
Polycystic ovary syndrome is another frequent reason for a raised LH, often with LH high relative to FSH. Research into diminished ovarian reserve, including work on intraovarian platelet-rich plasma, reports gonadotropin levels as one of the parameters that shift with ovarian function, and that literature is still early and clinician-gated[4]. Some medications raise LH by design, including selective estrogen receptor modulators such as clomiphene and enclomiphene, which have been studied in men with hypogonadism and work by releasing the pituitary from estrogen feedback[5].
The long-term picture depends on what sits underneath. Where a high LH reflects genuinely low estradiol or testosterone over years, that state is associated with reduced bone mineral density and unfavourable changes in body composition. A high LH that reflects PCOS is associated instead with insulin resistance and metabolic risk. Neither conclusion can be drawn from the LH value alone, and a result outside the standard range is worth discussing with a clinician who can see the full panel and your history.
A low or inappropriately normal LH alongside low sex hormones usually means the signal from the hypothalamus and pituitary is suppressed, a pattern clinicians call secondary or hypogonadotropic hypogonadism.
Reported symptoms overlap heavily with the high-LH picture because the downstream deficiency is similar. Women may notice light, infrequent or absent periods and difficulty conceiving. Men may notice low libido, fatigue, reduced erectile quality, loss of strength and poor recovery. Where a pituitary cause is involved, headaches or visual changes occasionally appear, and those symptoms are worth discussing with a clinician promptly rather than at the next routine visit.
Pituitary adenomas and other structural causes are less common but are part of the reason a persistently low LH is investigated rather than watched. A meta-analysis of GLP-1 receptor agonists and testicular function reported improvements in several hormonal parameters in men with obesity, which is consistent with the broader observation that metabolic state and gonadotropin signalling interact, though the evidence remains limited[6].
Over the long term, suppressed gonadotropins and the low sex hormone state that accompanies them are associated with reduced bone density, loss of lean mass and impaired fertility. Much of this is reversible when the underlying driver changes, but that judgement belongs to a licensed provider who can test the rest of the axis.
More than most biomarkers, an LH value reflects when and how it was measured, not only your underlying physiology.
Testing conditions. LH is secreted in pulses, so two samples taken an hour apart can differ. Morning sampling is common for consistency. In menstruating women, cycle day dominates everything else, and most panels are drawn in the early follicular phase unless the goal is to capture the surge. Urine LH ovulation test strips are a different tool, designed to detect the rise in LH before ovulation rather than to quantify a baseline level, and they are not a substitute for a blood test. Acute illness, a night of broken sleep or a hard training block can also shift a single reading.
Medications. Combined hormonal contraceptives suppress LH. Testosterone therapy suppresses it. GnRH agonists and antagonists alter it sharply. Clomiphene and enclomiphene raise it[5]. Always tell the ordering clinician what you take, including over-the-counter and performance supplements, since the interpretation changes completely with that context.
Metabolic and lifestyle factors. Insulin resistance, body composition and energy availability all influence gonadotropin signalling. In women with PCOS, interventions that target insulin sensitivity have been studied for their effect on hormonal parameters including LH. A meta-analysis comparing myo-inositol with metformin reported changes in hormonal and metabolic measures in both groups[7], and a separate review found that combining metformin with inositol was associated with further improvement in some parameters compared with metformin alone[8]. N-acetylcysteine has been reviewed in the same population with modest reported effects on hormonal and metabolic outcomes[9]. Dietary change has also been studied, with a systematic review of ketogenic diets in women with PCOS reporting improvements in weight and several endocrine parameters[10], and combined liraglutide and metformin therapy has been reviewed in overweight or obese women with PCOS[11]. Early and lower-quality evidence has also looked at acupuncture in men with poor semen parameters, reporting changes in sperm measures[12].
None of that is a recommendation, and no doses, schedules or administration details appear here by design. Metformin, GLP-1 medications, clomiphene, enclomiphene, testosterone therapy and women's hormone therapy are prescription treatments, and a licensed provider evaluates whether any of them is appropriate for a specific person.
LH is measured from a standard blood draw and sits on the hormone panel alongside FSH, sex steroids, SHBG and prolactin, which is the only way the result becomes interpretable.
Within the FitScript membership, LH is one of 150+ biomarkers tested per year, so the value is followed as a trend rather than read once and filed. Atlas, FitScript's AI health advisor, interprets LH in context, comparing it against FSH and the downstream sex hormones, flagging the pattern that result forms, and writing that interpretation into your FitScript, the personalised output built from your own biology. Repeat testing matters here more than usual, because a single pulsatile value drawn on an unknown cycle day can mislead in either direction.
Where results and symptoms suggest something worth acting on, a licensed provider reviews the full picture and decides what, if anything, is appropriate. Nothing on this page replaces that review, and any result outside the standard range deserves a conversation with a clinician rather than a self-directed fix.
LH is close to uninterpretable alone, so it is ordered with the markers that sit either side of it in the axis. FSH is the companion gonadotropin and the single most useful comparison, since the ratio between the two shapes how a result is read. Testosterone Total and Testosterone Free show what the testes or ovaries are actually producing and how much of it is biologically available, while SHBG explains much of the gap between those two numbers. In women, Estradiol reflects follicular activity and drives the feedback that produces the mid-cycle surge, and Progesterone drawn in the luteal phase is the practical confirmation that ovulation occurred. All of these appear together on FitScript's hormone lab panels, the Hormone Panel for him and the Hormone Panel for her, which is the point, since the pattern across the group carries the meaning.
Luteinizing hormone is the pituitary's instruction to the gonads. A high value usually suggests the ovaries or testes are not responding well enough, a low value suggests the instruction itself is suppressed, and a mid-cycle sample in a menstruating woman can look dramatic while being entirely normal. Reference ranges vary by lab, age, sex and cycle phase, and FitScript's optimal range of 2 to 9 mIU/mL is a tracking target rather than a diagnostic line. This article is educational and is not medical advice. Review your results and any treatment options with a clinician or licensed provider who can see your full history.
LH is made by the pituitary gland and acts on the ovaries and testes. In women it triggers ovulation and the formation of the corpus luteum that produces progesterone. In men it stimulates the Leydig cells of the testes to produce testosterone. It is the brain's instruction to the gonads, which is why it is read alongside the hormones those organs produce.
A typical adult lab reference range runs from about 1 to 15 mIU/mL, and FitScript's optimal range is 2 to 9 mIU/mL. Ranges vary by laboratory, assay, age and sex, and in menstruating women the value changes sharply across the cycle, so most labs report phase-specific ranges. Always compare your result with the range printed on your own report.
Most baseline hormone panels are drawn in the early follicular phase, within the first few days of the cycle, so the value is not distorted by the mid-cycle surge. If the goal is to confirm ovulation timing instead, the testing window is different. The ordering clinician should know your cycle day, since the same number means different things depending on when it was taken.
Urine LH test strips are designed to detect the sharp rise in LH that precedes ovulation, giving a yes or no style signal about timing. A blood test quantifies the level in mIU/mL and is used to assess the reproductive axis alongside FSH and sex hormones. Strips are useful for cycle tracking but they do not replace a laboratory measurement.
Yes. Testosterone taken from outside the body replaces the feedback signal the brain normally receives, so LH typically falls, sometimes to very low levels. That is one reason clinicians measure LH before starting any hormone therapy rather than after. Whether testosterone therapy is appropriate for a specific person is a decision a licensed provider makes after evaluating the full picture.
In PCOS, LH is often elevated relative to FSH, which is thought to reflect altered GnRH pulse frequency from the hypothalamus along with insulin resistance and raised androgens. It is a pattern seen in many people with PCOS rather than a diagnostic test on its own, and the condition is diagnosed clinically using symptoms, imaging and several hormone results together.
That combination suggests the pituitary is signalling normally or even harder than usual while the testes are not responding, a pattern clinicians investigate as primary testicular insufficiency. It is a direction for investigation, not a diagnosis, and it is worth discussing with a clinician who can order confirmatory testing and review your history.
Indirectly, yes. Energy availability, sleep, training load, alcohol and body composition all influence the hypothalamic signal that drives LH. Effects vary between people, and persistent abnormal results still need clinical assessment rather than a self-directed fix.
Because LH is released in pulses and shifts with the menstrual cycle, a single value is a snapshot. Retesting frequency depends on why it was measured and what the rest of the panel showed, so the interval should be set by the clinician reviewing your results. Tracking the marker across repeat panels is generally more informative than any one reading.